BioCatalyst

ECC4703, Semaglutide — catalyst calendar

1 verified catalyst event(s) referencing ECC4703, Semaglutide, each linked to its official source. Verified as of 2026-08-06.

Upcoming

DateEventCompanyDrugOfficial source & verification
2026-10-15
in 2mo
ESTIMATED
 READOUT
MIST (Metabolic Intervention With Semaglutide and THR-β Therapy) Trial
Phase 2 · Adult Obesity, Weight Management
 Eccogene ECC4703, Semaglutide ClinicalTrials.gov ↗
✓ Source-checked 2026-08-06
Sponsor-projected date — can change
Disclaimer. Bio Catalyst Calendar is a public-events data calendar. Every date is sourced and linked to an official record (ClinicalTrials.gov, FDA / Federal Register, openFDA). It is scheduling and reference data only — NOT investment advice, a recommendation, or a buy/sell signal. Dates set by sponsors and the FDA can change; always confirm against the linked official source.